ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double

Benzinga2021-11-11

ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million. The increase was favorably impacted by the continued commercial ramp-up of ADMA's ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

szueyann
2021-11-11
szueyann
Like pls
- szueyann:
  ok
Vall
2021-11-11
Vall
Like
- szueyann:
  ok
Dindindino
2021-11-11
Dindindino
Like
- szueyann:
  ok
- Vall:
  Ok.
jovrene
2021-11-11
jovrene
Ok
- Dindindino:
  Ok
Gaik11
2021-11-11
Gaik11
Okay
- jovrene:
  ok
- Gaik11:
  Ok
Wheee
2021-11-11
Wheee
Like
- szueyann:
  ok
- Nana_seven:
  Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1156346284?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-11 21:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156346284","market":"us","top_or_hot":-1,"title":"ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double","media":"Benzinga","content":"<div>\n<p>ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.\nThe increase was favorably impacted by the continued commercial ramp-up of ADMA's ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.\nThe increase was favorably impacted by the continued commercial ramp-up of ADMA's ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADMA","symbol_name":"ADMA Biologics Inc","start_time":0,"source_url":"https://www.benzinga.com/general/biotech/21/11/24036746/adma-biologics-shares-rise-on-lower-than-expected-q3-loss-sales-double","article_id":"1156346284","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156346284","pubTimestamp":1636636405,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 m","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADMA":"ADMA Biologics Inc"},"translate_title":"ADMA Biologics股价上涨，第三季度亏损低于预期，销售翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADMA":0.9},"content_text":"ADMA Biologics Inc achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million.\nThe increase was favorably impacted by the continued commercial ramp-up of ADMA's intravenous immune globulin (IVIG) product portfolio and the sale of intermediate fractions.\nThe company generated a gross profit of $0.4 million compared to a gross loss of $(1.6) million a year ago, primarily attributable to increased sales of ADMA's higher-margin hyperimmune globulin product portfolio, along with a portion of the sales generated from conformance batches.\nQ3 consolidated net loss reached $(17.7) million, compared to $(16.9) million last year. EPS loss was $(0.13) compared to $(0.19) a year ago, better than the consensus of $(0.14).\nADMA had cash and equivalents of $34.4 million and accounts receivable of $20.4 million as of September 30, 2021. On October 25, 2021, the company raised $53.9 million through a public offering.\nPrice Action: ADMA shares are up 10.7% at $1.55 during the premarket session on the last check Thursday.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":870468186,"gmtCreate":1636642608686,"gmtModify":1636642610831,"author":{"id":"3573721781255613","authorId":"3573721781255613","name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870468186","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6539582,"gmtCreate":1636642613353,"gmtModify":1636642613470,"authorId":3573721781255613,"author":{"id":3573721781255613,"authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870468186,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":870547244,"gmtCreate":1636639277989,"gmtModify":1636639278261,"author":{"id":"4089111593463300","authorId":"4089111593463300","name":"Vall","avatar":"https://static.tigerbbs.com/fe90033351c83d258018a489920a2d49","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870547244","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6539583,"gmtCreate":1636642622207,"gmtModify":1636642622238,"authorId":3573721781255613,"author":{"id":3573721781255613,"authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870547244,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":870545819,"gmtCreate":1636639038606,"gmtModify":1636639038919,"author":{"id":"3585008979244156","authorId":"3585008979244156","name":"Dindindino","avatar":"https://static.tigerbbs.com/8aa54f4d7f1ed33d80d2d8d18918fb30","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/870545819","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6539584,"gmtCreate":1636642628321,"gmtModify":1636642628351,"authorId":3573721781255613,"author":{"id":3573721781255613,"authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870545819,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6538789,"gmtCreate":1636639270832,"gmtModify":1636639270925,"authorId":4089111593463300,"author":{"id":4089111593463300,"authorId":4089111593463300,"name":"Vall","avatar":"https://static.tigerbbs.com/fe90033351c83d258018a489920a2d49","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870545819,"type":1,"supId":0,"prevId":0,"content":"Ok.","text":"Ok.","html":"Ok."}],"langContent":"CN"},{"id":870549902,"gmtCreate":1636638161759,"gmtModify":1636638162104,"author":{"id":"4095592624574210","authorId":"4095592624574210","name":"jovrene","avatar":"https://static.tigerbbs.com/a068b755584903947da2a9b01a9599de","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870549902","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538769,"gmtCreate":1636639035767,"gmtModify":1636639035801,"authorId":3585008979244156,"author":{"id":3585008979244156,"authorId":3585008979244156,"name":"Dindindino","avatar":"https://static.tigerbbs.com/8aa54f4d7f1ed33d80d2d8d18918fb30","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870549902,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":870540231,"gmtCreate":1636638097850,"gmtModify":1636638154013,"author":{"id":"3578020712938440","authorId":"3578020712938440","name":"Gaik11","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/870540231","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6538674,"gmtCreate":1636638174257,"gmtModify":1636638174365,"authorId":4095592624574210,"author":{"id":4095592624574210,"authorId":4095592624574210,"name":"jovrene","avatar":"https://static.tigerbbs.com/a068b755584903947da2a9b01a9599de","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870540231,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6538662,"gmtCreate":1636638105303,"gmtModify":1636638105398,"authorId":3578020712938440,"author":{"id":3578020712938440,"authorId":3578020712938440,"name":"Gaik11","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870540231,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":870556746,"gmtCreate":1636637716755,"gmtModify":1636637717131,"author":{"id":"3580123620847057","authorId":"3580123620847057","name":"Wheee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/870556746","repostId":1156346284,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6539588,"gmtCreate":1636642637797,"gmtModify":1636642637874,"authorId":3573721781255613,"author":{"id":3573721781255613,"authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870556746,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6538588,"gmtCreate":1636637821525,"gmtModify":1636637821555,"authorId":3575673754947065,"author":{"id":3575673754947065,"authorId":3575673754947065,"name":"Nana_seven","avatar":"https://static.tigerbbs.com/cbfa864cf0a3b766b4090b0ad3b67e69","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":870556746,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":46,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156346284"}